Literature DB >> 28259446

Syk expression and IgE-mediated histamine release in basophils as biomarkers for predicting the clinical efficacy of omalizumab.

Donald W MacGlashan1, Sarbjit S Saini2.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28259446     DOI: 10.1016/j.jaci.2016.12.965

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


× No keyword cloud information.
  6 in total

1.  Autoantibodies to IgE and FcεRI and the natural variability of spleen tyrosine kinase expression in basophils.

Authors:  Donald MacGlashan
Journal:  J Allergy Clin Immunol       Date:  2018-06-01       Impact factor: 10.793

Review 2.  Role of Basophils in a Broad Spectrum of Disorders.

Authors:  Kensuke Miyake; Junya Ito; Hajime Karasuyama
Journal:  Front Immunol       Date:  2022-05-27       Impact factor: 8.786

3.  The efficacy of omalizumab treatment in chronic spontaneous urticaria is associated with basophil phenotypes.

Authors:  Kirti J Johal; Kristin L Chichester; Eric T Oliver; Kelly C Devine; Anja P Bieneman; John T Schroeder; Donald W MacGlashan; Sarbjit S Saini
Journal:  J Allergy Clin Immunol       Date:  2021-03-10       Impact factor: 14.290

Review 4.  Basophil Activation Test: Old and New Applications in Allergy.

Authors:  Oliver Hemmings; Matthew Kwok; Richard McKendry; Alexandra F Santos
Journal:  Curr Allergy Asthma Rep       Date:  2018-11-15       Impact factor: 4.806

5.  Response of FcεRI-bearing leucocytes to omalizumab in chronic spontaneous urticaria.

Authors:  Mehran Alizadeh Aghdam; Edward F Knol; Mignon van den Elzen; Constance den Hartog Jager; Harmieke van Os-Medendorp; André C Knulst; Henny G Otten; Heike Röckmann
Journal:  Clin Exp Allergy       Date:  2020-02-07       Impact factor: 5.018

Review 6.  The Use of Biomarkers to Predict Aero-Allergen and Food Immunotherapy Responses.

Authors:  Sayantani B Sindher; Andrew Long; Swati Acharya; Vanitha Sampath; Kari C Nadeau
Journal:  Clin Rev Allergy Immunol       Date:  2018-10       Impact factor: 8.667

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.